Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical update

Por Aprile, Giuseppe, Rihawi, Karim, De Carlo, Elisa, Sonis, Stephen T
Publicado no World J Gastroenterol (2015)

Ramucirumab: preclinical research and clinical development

Por Aprile, Giuseppe, Rijavec, Erika, Fontanella, Caterina, Rihawi, Karim, Grossi, Francesco
Publicado no Onco Targets Ther (2014)

Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?

Por Bonotto, Marta, Gerratana, Lorenzo, Iacono, Donatella, Minisini, Alessandro Marco, Rihawi, Karim, Fasola, Gianpiero, Puglisi, Fabio
Publicado no Oncologist (2015)

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Mana...

Por Khan, Khurum H., Wong, Mabel, Rihawi, Karim, Bodla, Shankar, Morganstein, Daniel, Banerji, Udai, Molife, Lulama R.
Publicado no Oncologist (2016)

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example

Por Gerratana, Lorenzo, De Maglio, Giovanna, De Pellegrin, Alessandro, Follador, Alessandro, Rihawi, Karim, Pizzolitto, Stefano, Puglisi, Fabio, Fasola, Gianpiero
Publicado no Onco Targets Ther (2016)

Higher risk of infections with PI3K-AKT-mTOR pathway inhibitors in patients with advanced solid tumors on Phase I clinical trials

Por Rafii, Saeed, Roda, Desamparados, Geuna, Elena, Jimenez, Begona, Rihawi, Karim, Capelan, Marta, Yap, Timothy A, Molife, L Rhoda, Kaye, Stanley B, de Bono, Johann S, Banerji, Udai
Publicado no Clin Cancer Res (2015)

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials

Por Aprile, Giuseppe, Fontanella, Caterina, Bonotto, Marta, Rihawi, Karim, Lutrino, Stefania Eufemia, Ferrari, Laura, Casagrande, Mariaelena, Ongaro, Elena, Berretta, Massimiliano, Avallone, Antonio, Rosati, Gerardo, Giuliani, Francesco, Fasola, Gianpiero
Publicado no Oncotarget (2015)

HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives

Por Fanotto, Valentina, Ongaro, Elena, Rihawi, Karim, Avallone, Antonio, Silvestris, Nicola, Fornaro, Lorenzo, Vasile, Enrico, Antonuzzo, Lorenzo, Leone, Francesco, Rosati, Gerardo, Giuliani, Francesco, Bordonaro, Roberto, Scartozzi, Mario, Maglio, Giovanna De, Negri, Francesca V., Fasola, Gianpiero, Aprile, Giuseppe
Publicado no Oncotarget (2016)